Bharat Biotech to collaborate with Hilleman to develop cholera vaccine

Hilleman Laboratories announced on Wednesday that it will collaborate with Hyderabad-based vaccine maker Bharat Biotech International Limited (BBIL) for further development, manufacture and commercialisation of its next generation oral cholera vaccine, Hillchol.

Hillchol was designed at the University of Gothenburg in Sweden and subsequently developed by Hilleman Labs. The development process included demonstration of safety and imnmunogenicity in an age de-escalating phase I/II clinical trial conducted in Bangladesh.

For further development of the vaccine candidate, Hilleman Labs has entered into a licensing and manufacturing agreement with BBIL, which will scale the manufacturing process to commercial stage and establish product specifications required for